Letrozole
Drug Details
- Description
- Letrozole is an oral nonsteroidal aromatase inhibitor used primarily for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by decreasing estrogen levels in the body, which can slow or stop the growth of certain types of breast tumors that require estrogen to grow.
- Alternative Names
- Letrozole is commonly known by its brand name, Femara.
- Key Genes
- Key genes associated with Letrozole include CYP19A1, ESR1, and ESR2.
- Drug Use
- Letrozole is used to treat hormone receptor-positive breast cancer in postmenopausal women. It can be used as adjuvant treatment, extended adjuvant treatment, or for metastatic breast cancer. It works by decreasing estrogen levels.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report